基本信息
文件名称:Elvitegravir-13C6-GS-9137-sup-13-sup-C-sub-6-sub-生命科学试剂-MCE.pdf
文件大小:465.26 KB
总页数:1 页
更新时间:2025-05-20
总字数:约2.82千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Elvitegravir-13C6

Cat.No.:HY-14740S2

Synonyms:GS-9137-13C;JTK-303-13C;D06677-13C

666

分?式:C????C?H??ClFNO?

分?量:450.82

作?靶点:Isotope-LabeledCompounds;HIVIntegrase;HIV

作?通路:Others;MetabolicEnzyme/Protease;Anti-infection

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Elvitegravir-13C6(GS-9137-13C6)是13C标记的Elvitegravir.Elvitegravir(GS-9137;JTK-303;D06677)是?

种HIVintegrase抑制剂,作?于HIV-1IIIB,HIV-2EHO和HIV-2ROD,IC50分别为0.7nM,2.8nM和1.4

nM。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.ImpactofDeuteriumSubstitut